Final answer:
Growth hormone therapy in children with PWS aids in muscle development and can help manage the growth and nutritional difficulties associated with the syndrome, potentially improving life expectancy.
Step-by-step explanation:
Growth hormone therapy for children with Prader-Willi Syndrome (PWS) helps with increased muscular development and can contribute to reducing some of the nutritional and growth challenges brought on by the condition. These therapies take advantage of the growth hormone (GH) produced by the anterior pituitary to promote protein synthesis and body growth.
Since individuals with PWS tend to have difficulty reaching sexual maturity and regulating hunger and eating due to hypothalamic abnormalities, GH therapy can assist in the crucial period of development during childhood to mitigate the effects of the syndrome, potentially improving quality of life and life expectancy.